A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients

(2010) Linda Hertlein et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells

(2010) Arun Satelli et al.   CANCER LETTERS

Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells

(2010) Xu-Yun Zhao et al.   CARCINOGENESIS

H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output

(2010) Barak Rotblat et al.   PLoS One

Single Nucleotide Polymorphisms of DNA Repair Genes as Predictors of Radioresponse

(2010) Matthew B. Parliament et al.   SEMINARS IN RADIATION ONCOLOGY

Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial

(2009) J.E. Kurtz et al.   GYNECOLOGIC ONCOLOGY

Multivariate Analysis of Para-Aortic Lymph Node Recurrence After Definitive Radiotherapy for Stage IB-IVA Squamous Cell Carcinoma of Uterine Cervix

(2008) Eng-Yen Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Protein-glycan interactions in the control of innate and adaptive immune responses

(2008) Yvette van Kooyk et al.   NATURE IMMUNOLOGY

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

(2007) A. Goncalves et al.   GYNECOLOGIC ONCOLOGY

Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma

(2007) Wei-Fan Chiang et al.   ORAL ONCOLOGY